Abstract
The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust surveillance, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential viral growth, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance. Given the pattern of viral load kinetics, we model surveillance effectiveness considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective surveillance depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity. We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.
Introduction
The primary challenge of the COVID-19 pandemic is "silent" spread—transmission from individuals who are asymptomatic or pre-symptomatic. To mitigate this, public health strategies rely heavily on surveillance testing. However, there is an ongoing debate regarding the trade-offs between clinical sensitivity and surveillance utility. Clinical sensitivity favors high-end laboratory tests like RT-qPCR, which can detect minute amounts of viral RNA but are often expensive and slow. Surveillance utility, conversely, favors cheaper, faster, but "less sensitive" tests (e.g., rapid antigen tests) that can be deployed frequently at scale. This study investigates which of these factors—sensitivity, frequency, or turnaround time—is most critical for breaking transmission chains.
Methods and Modeling
The researchers utilized a combination of viral kinetics modeling and epidemiological simulations. Viral load trajectories were stochastically generated based on existing literature to capture the incubation period, rapid exponential growth, peak viral load, and the clearance phase. Infectiousness was modeled as proportional to the logarithm of the viral load, assuming peak contagiousness occurs at high viral titers (above $10^6$ copies/ml).
To validate the findings, two distinct epidemiological models were employed:
- Fully-Mixed Model: A stochastic simulation of 20,000 individuals, representing a university or large workplace.
- Agent-Based Model: A complex simulation of 8.4 million agents based on New York City census data, incorporating household structures and age-stratified contact matrices.
The Negligible Impact of Analytical Sensitivity
A primary finding is that the "head start" provided by highly sensitive tests is minimal. Due to the exponential growth of the virus, the time required to progress from a high-sensitivity detection limit ($10^3$ cp/ml) to a lower-sensitivity limit ($10^5$ cp/ml) is typically less than 24 hours. Consequently, a more sensitive test only provides a tiny window of extra time for intervention.
Frequency and Speed as Primary Drivers
The simulations demonstrate that testing frequency and reporting speed are the most critical factors in suppressing an outbreak. Testing every 3 days with a lower-sensitivity test (LOD $10^5$) was shown to reduce total infectiousness by approximately 80%. In contrast, testing every 14 days with a "gold-standard" PCR test (LOD $10^3$) only achieved a 25% reduction.
Furthermore, reporting delays significantly undermine testing effectiveness. A 2-day delay in returning results reduced the impact of a testing program by nearly half, as individuals often pass their peak infectious period before receiving their diagnosis. Frequent testing acts as a filter, catching cases missed in previous rounds due to false negatives or low initial viral loads.
Conclusion
Effective COVID-19 surveillance should prioritize testing frequency and rapid turnaround time over analytical sensitivity. Frequent, rapid testing acts as a high-pass filter, identifying and isolating the most infectious individuals during their peak window of transmission. While high sensitivity remains a priority for clinical diagnosis, surveillance programs should focus on accessibility and speed to effectively drive the epidemic to extinction.
Summary updated